ICD-10 category · Morphology of neoplasms · M814-M838
M824 Adenomas and adenocarcinomas
23 codes under M824 in the South African Master Industry Table 2021, 23 valid for clinical use.
| Code | Description | Use | Benefits |
|---|---|---|---|
| M8240/1 | Carcinoid tumour NOS, of appendix, uncertain whether benign or malignant (D37.3) | Valid · not as primary | — |
| M8240/3 | Carcinoid tumour, NOS, malignant, primary site (except of appendix M8240/1) | Valid · not as primary | — |
| M8240/6 | Carcinoid tumour, NOS, malignant, metastatic site | Valid · not as primary | — |
| M8241/1 | Carcinoid tumour, argentaffin NOS, uncertain whether benign or malignant | Valid · not as primary | — |
| M8241/3 | Carcinoid tumour, argentaffin, malignant, primary site | Valid · not as primary | — |
| M8241/6 | Carcinoid tumour, argentaffin, malignant, metastatic site | Valid · not as primary | — |
| M8242/1 | Enterochromaffin-like cell carcinoid, NOS, uncertain whether benign or malignant | Valid · not as primary | — |
| M8242/3 | Enterochromaffin-like cell tumour, malignant, primary site | Valid · not as primary | — |
| M8242/6 | Enterochromaffin-like cell tumour, malignant, metastatic site | Valid · not as primary | — |
| M8243/3 | Goblet cell carcinoid, malignant, primary site (C18.1) | Valid · not as primary | — |
| M8243/6 | Goblet cell carcinoid, malignant, metastatic site | Valid · not as primary | — |
| M8244/3 | Mixed adenoneuroendocrine carcinoma, malignant, primary site | Valid · not as primary | — |
| M8244/6 | Mixed adenoneuroendocrine carcinoma, malignant, metastatic site | Valid · not as primary | — |
| M8245/1 | Tubular carcinoid, uncertain whether benign or malignant | Valid · not as primary | — |
| M8245/3 | Adenocarcinoid tumour, malignant, primary site | Valid · not as primary | — |
| M8245/6 | Adenocarcinoid tumour, malignant, metastatic site | Valid · not as primary | — |
| M8246/3 | Neuroendocrine carcinoma, malignant, primary site | Valid · not as primary | — |
| M8246/6 | Neuroendocrine carcinoma, malignant, metastatic site | Valid · not as primary | — |
| M8247/3 | Merkel cell carcinoma, malignant, primary site (C44.-) | Valid · not as primary | — |
| M8247/6 | Merkel cell carcinoma, malignant, metastatic site | Valid · not as primary | — |
| M8248/1 | Apudoma, uncertain whether benign or malignant | Valid · not as primary | — |
| M8249/3 | Neuroendocrine carcinoma, moderately differentiated, malignant, primary site | Valid · not as primary | — |
| M8249/6 | Neuroendocrine carcinoma, moderately differentiated, malignant, metastatic site | Valid · not as primary | — |
Source and terms
Reproduced from the national table, unaltered.
The Department publishes the table for the industry to load. The ICD-10 Master Industry Table page
Codes and descriptions: ICD-10 Master Industry Table (MIT) 2021, published 16 March 2021 by the National Department of Health, Republic of South Africa. ® National Department of Health: all rights reserved. Reproduced for reference without alteration.
ICD-10 is the International Statistical Classification of Diseases and Related Health Problems, Tenth Revision, © World Health Organization. The WHO ICD-10 descriptions appear as published in the MIT.
Prescribed Minimum Benefit (PMB) and Chronic Disease List (CDL) markers: Council for Medical Schemes, PMB Coded List, as read by GreenNotes. Benefit decisions rest with each medical scheme.
Source file: ICD-10_MIT_2021_Excel_16-March_2021.xlsx. Found an error in a code or description? Write to help@greennotes.co.za.
In GreenNotes
Code the consultation once. The invoice and the claim pick it up.
GreenNotes looks codes up from this same table while you write the consultation. The codes you record there, including any the clinical AI included for your review, carry into the invoice and the medical-aid claim.